Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Accelerated Approvals Could Have Expiration Dates, Annual Reviews To Promote Confirmatory Trials, ICER Suggests
Apr 29 2021
•
By
Cathy Kelly
Cumulative Annual Net Cost For Many Accelerated Approvals Could Exceed $150,000
More from Review Pathways
More from Pathways & Standards